Literature DB >> 2354591

Clearance from dialysate and equilibration of intraperitoneal vancomycin in continuous ambulatory peritoneal dialysis.

D Neal1, G R Bailie.   

Abstract

This article reports on a study of the disposition of loading doses (1g and 15 mg/kg) of vancomycin given intraperitoneally to 6 patients on continuous ambulatory peritoneal dialysis with Gram-positive peritonitis. Dialysate samples were collected every 30 minutes during the first dwell, and serum samples were collected after the first 5 exchanges and after 7 or 14 days. The dialysate concentration/time data were fitted to a monoexponential curve for 4 patients and to a biexponential curve for 2 others. Dialysis clearance was 0.73 +/- 0.04 L/h (1g dose) and 0.70 +/- 0.23 L/h (15 mg/kg dose). Total body clearance was 0.51 +/- 0.36 L/h. Serum concentrations reached 14 to 18 mg/L (15 mg/kg dose) and 6.75 to 24 mg/L (1g dose) at the end of the first dwell. The half-life of equilibration of vancomycin across the peritoneal membrane was 2.5 +/- 2.3 hours. Intraperitoneal loading doses of vancomycin produce concomitant serum concentrations in excess of the minimum inhibitory concentrations for susceptible organisms. Administration on a milligram per kilogram basis produces more consistent serum concentrations than using a standard loading dose which is not based on bodyweight.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2354591     DOI: 10.2165/00003088-199018060-00005

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  14 in total

1.  Sensitive bioassay for vancomycin.

Authors:  C A Walker; B Kopp
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

2.  Diagnosis and management of peritonitis in continuous ambulatory peritoneal dialysis. Report of a working party of the British Society for Antimicrobial Chemotherapy.

Authors: 
Journal:  Lancet       Date:  1987-04-11       Impact factor: 79.321

3.  Intravenous or intraperitoneal vancomycin for the treatment of continuous ambulatory peritoneal dialysis associated gram-positive peritonitis?

Authors:  G R Bailie; R Morton; L Ganguli; M Keaney; S Waldek
Journal:  Nephron       Date:  1987       Impact factor: 2.847

4.  Peritoneal transport of vancomycin in 4 patients undergoing continuous ambulatory peritoneal dialysis.

Authors:  S Pancorbo; C Comty
Journal:  Nephron       Date:  1982       Impact factor: 2.847

5.  Intraperitoneal (IP) vancomycin therapy for CAPD peritonitis--a prospective, randomized comparison of intermittent v continuous therapy.

Authors:  N W Boyce; C Wood; N M Thomson; P Kerr; R C Atkins
Journal:  Am J Kidney Dis       Date:  1988-10       Impact factor: 8.860

6.  Vancomycin disposition during continuous ambulatory peritoneal dialysis: a pharmacokinetic analysis of peritoneal drug transport.

Authors:  M C Rogge; C A Johnson; S W Zimmerman; P G Welling
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

7.  Vancomycin kinetics during continuous ambulatory peritoneal dialysis.

Authors:  C M Bunke; G R Aronoff; M E Brier; R S Sloan; F C Luft
Journal:  Clin Pharmacol Ther       Date:  1983-11       Impact factor: 6.875

8.  Comparative study of intraperitoneal and intravenous vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis.

Authors:  G D Morse; D F Farolino; M A Apicella; J J Walshe
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

9.  Peritonitis in continuous ambulatory peritoneal dialysis patients.

Authors:  J Rubin; R Ray; T Barnes; N Teal; E Hellems; J Humphries; J D Bower
Journal:  Am J Kidney Dis       Date:  1983-05       Impact factor: 8.860

10.  Vancomycin pharmacokinetics in continuous ambulatory peritoneal dialysis patients with peritonitis.

Authors:  A M Harford; D A Sica; T Tartaglione; R E Polk; H P Dalton; W Poynor
Journal:  Nephron       Date:  1986       Impact factor: 2.847

View more
  2 in total

1.  Prediction of serum vancomycin concentrations following intraperitoneal loading doses in continuous ambulatory peritoneal dialysis patients with peritonitis.

Authors:  G R Bailie; G Eisele; R A Venezia; D Yocum; A Hollister
Journal:  Clin Pharmacokinet       Date:  1992-04       Impact factor: 6.447

2.  Vancomycin: the tale of the vanquisher and the pyrrhic victory.

Authors:  An S De Vriese; Stefaan J Vandecasteele
Journal:  Perit Dial Int       Date:  2014 Mar-Apr       Impact factor: 1.756

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.